BioTech

Source: globenewswire.com MacroGenics Inc. has announced positive results from SOPHIA, a Phase 3 clinical study of margetuximab in HER2-positive metastatic breast cancer patients. Margetuximab is...

ROCKLAND, Mass. and NEW YORK, May 14, 2019 /PRNewswire/ -- BAVENCIO is the first anti-PD-L1 in combination with INLYTA approved by FDA for first-line treatmen

Source: globenewswire.com Columbia based, Osiris Therapeutics (NASDAQ: OSIR), is engaged in the research, development, and manufacturing of regenerative medicine products intended to improve the health...

Source: globenewswire.com The European Commission has given approval to Roche’s drug MabThera (rituximab). This drug helps treat adults with moderate to severe pemphigus vulgaris (PV),...

Source: www.novartis.com The US Food and Drug Administration (FDA) has granted Novartis Breakthrough Therapy designation for its investigational therapy crizanlizumab (SEG101). This revolutionary treatment is...

Although it was probably not in serious jeopardy, Bristol-Myers Squibb’s shareholders voted today to approve the acquisition of Celgene Corporation for about $74 billion.

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today results from the Ph

WALTHAM, Mass., May 16, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that i

Source: www.news.sanofi.us The U.S. Food and Drug Administrator (FDA) has given its approval for Sanofi and Merck’s drug VAXELIS. This drug can be used as...

DUBLIN, March 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™